Clinical Trials Browser

Phase 2 × Completed × prexasertib × Clear all

NCT02873975 2022-10-21

A Study of LY2606368 (Prexasertib) in Patients With Solid Tumors With Replicative Stress or Homologous Repair Deficiency

Phase 2 Completed

27 enrolled 13 charts

Classical hematology

Fanconi Anemia

NCT03414047 2022-08-19

A Study of Prexasertib (LY2606368) in Platinum-Resistant or Refractory Recurrent Ovarian Cancer

Phase 2 Completed

172 enrolled 19 charts

Ovarian Neoplasms

NCT02735980 2020-03-17

A Study of Prexasertib (LY2606368) in Participants With Extensive Stage Disease Small Cell Lung Cancer

Phase 2 Completed

133 enrolled 20 charts

Small Cell Lung Carcinoma